Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Sleep Wake Disorders 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Obesity 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Kidney Neoplasms 1Hematologic Neoplasms 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Castration-Resistant Prostate Cancer (CRPC) 1Carcinoma, Renal Cell 1

Interventions

cabozantinib 4Nivolumab 2Ipilimumab 2zimberelimab 1temsirolimus 1salicylhydroxamic acid 1orellanine 1atezolizumab 1Surveys and Questionnaires 1Ropivacaine 1Pluvicto 1Methods 1Health Promotion 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Erlotinib Hydrochloride 1Educational Status 1Early Intervention, Educational 1Docetaxel 1Dacarbazine 1Counseling 1Blood Component Removal 1Axitinib 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × Counseling × 30 days × Clear all
NCT05056077 2026-06-02

TTBF

University of California, San Francisco

Phase NA Active not recruiting
353 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Kidney Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡